166 related articles for article (PubMed ID: 2803802)
1. [A ten-year-old autistic girl with neuroleptic malignant syndrome caused by neuroleptic agents].
Horikawa M; Ninomiya M; Nishi M; Ando H; Yamashita Y; Terasawa K; Katafuchi Y
No To Hattatsu; 1989 Sep; 21(5):486-90. PubMed ID: 2803802
[TBL] [Abstract][Full Text] [Related]
2. [A study of neuroleptic malignant syndrome in the presenium and senium].
Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
[TBL] [Abstract][Full Text] [Related]
3. The neuroleptic malignant syndrome: occurrence in a 15-year-old boy and recovery with bromocriptine therapy.
Tenenbein M
Pediatr Neurosci; 1985-1986; 12(3):161-4. PubMed ID: 3870437
[TBL] [Abstract][Full Text] [Related]
4. Neuroleptic malignant syndrome in a 4-year-old girl associated with alimemazine.
van Maldegem BT; Smit LM; Touw DJ; Gemke RJ
Eur J Pediatr; 2002 May; 161(5):259-61. PubMed ID: 12012220
[TBL] [Abstract][Full Text] [Related]
5. Diagnosis and treatment of neuroleptic malignant syndrome.
Guerrero RM; Shifrar KA
Clin Pharm; 1988 Sep; 7(9):697-701. PubMed ID: 3240662
[TBL] [Abstract][Full Text] [Related]
6. [Catatonia in a 14 year-old girl: treatment with clorazepam and carbamazepine, a 10-year follow-up].
Askenazy F; Dor E; Benoit M; Dupuis G; Serret S; Myquel M; Seddiki Y
Encephale; 2010 Feb; 36(1):46-53. PubMed ID: 20159196
[TBL] [Abstract][Full Text] [Related]
7. Neuroleptic malignant syndrome in a patient on long-term olanzapine treatment at a stable dose: Successful treatment with dantrolene.
Kouparanis A; Bozikas A; Spilioti M; Tziomalos K
Brain Inj; 2015; 29(5):658-60. PubMed ID: 25625410
[TBL] [Abstract][Full Text] [Related]
8. Neuroleptic malignant syndrome during haloperidol treatment in a cancer patient. A case report.
Tanaka K; Akechi T; Yamazaki M; Hayashi R; Nishiwaki Y; Uchitomi Y
Support Care Cancer; 1998 Nov; 6(6):536-8. PubMed ID: 9833304
[TBL] [Abstract][Full Text] [Related]
9. [A patient with Parkinson's disease complicated by hypothyroidism who developed malignant syndrome after discontinuation of etizolam].
Kawajiri M; Ohyagi Y; Furuya H; Araki T; Inoue N; Esaki S; Yamada T; Kira J
Rinsho Shinkeigaku; 2002 Feb; 42(2):136-9. PubMed ID: 12424963
[TBL] [Abstract][Full Text] [Related]
10. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
Khouri C; Planès S; Logerot S; Villier C; Mallaret M
Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
[TBL] [Abstract][Full Text] [Related]
11. [Neuroleptic malignant syndrome after treatment with olanzapine].
Emborg C
Ugeskr Laeger; 1999 Mar; 161(10):1424-5. PubMed ID: 10085753
[TBL] [Abstract][Full Text] [Related]
12. [Prolonged neuroleptic malignant syndrome after Haloperidol injection].
Wystub N; Heymel S; Fritzenwanger M; Schulze PC; Pfeifer R
Med Klin Intensivmed Notfmed; 2018 Apr; 113(3):212-216. PubMed ID: 28752347
[TBL] [Abstract][Full Text] [Related]
13. Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) and disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease.
Yamawaki Y; Ogawa N
Intern Med; 1992 Nov; 31(11):1298-302. PubMed ID: 1295627
[TBL] [Abstract][Full Text] [Related]
14. Neuroleptic malignant syndrome: observations on altered consciousness.
Deuschl G; Oepen G; Hermle L; Kindt H
Pharmacopsychiatry; 1987 Jul; 20(4):168-70. PubMed ID: 3615574
[TBL] [Abstract][Full Text] [Related]
15. [A case of neuroleptic malignant syndrome caused by discontinuation of psychotropic drugs].
Takahashi Y; Yaguchi M; Yaguchi H; Togashi A; Suzuki M
Rinsho Shinkeigaku; 2022 Nov; 62(11):850-855. PubMed ID: 36288965
[TBL] [Abstract][Full Text] [Related]
16. [A successfully treated parkinsonian patient with neuroleptic malignant syndrome complicated by status epilepticus and disseminated intravascular coagulation].
Osoegawa M; Motomura S; Yamanaka H; Tamura K; Miyoshi T
Rinsho Shinkeigaku; 1999 Jun; 39(6):653-7. PubMed ID: 10502992
[TBL] [Abstract][Full Text] [Related]
17. Therapy of neuroleptic malignant syndrome.
Lazarus A
Psychiatr Dev; 1986; 4(1):19-30. PubMed ID: 3703852
[TBL] [Abstract][Full Text] [Related]
18. Risperidone-induced neuroleptic malignant syndrome.
Sharma R; Trappler B; Ng YK; Leeman CP
Ann Pharmacother; 1996; 30(7-8):775-8. PubMed ID: 8826559
[TBL] [Abstract][Full Text] [Related]
19. [Successful treatment of levodopa-induced neuroleptic malignant syndrome (NMS) with disseminated intravascular coagulation (DIC) in a patient with Parkinson's disease].
Yamawaki Y; Ogawa N
Rinsho Shinkeigaku; 1991 Jan; 31(1):62-7. PubMed ID: 2044308
[TBL] [Abstract][Full Text] [Related]
20. Neuroleptic malignant syndrome with delayed onset of fever following risperidone administration.
Norris B; Angeles V; Eisenstein R; Seale JP
Ann Pharmacother; 2006 Dec; 40(12):2260-4. PubMed ID: 17119106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
